Etodolace in pharma franchise in Mizoram

Etodolace in PCD pharma franchise in Hyderabad

Etodolace in top pharma company in Srinagar

Etodolace in pcd pharma supplier in Howrah

Etodolace in phama franchise company in India
Etodolace in phama distributor in Belagavi

Home/Products /etodolac-600mg-tablet

Edofoam ER 600 Tablet

Composition : Etodolac (600mg)

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹243/-

Edofoam 600 Tablet contains Etodolac (600mg), a potent non-steroidal anti-inflammatory drug (NSAID) designed to alleviate pain and inflammation associated with various conditions. It is particularly effective in managing arthritis-related discomforts, including stiffness, swelling, and joint pain, offering patients improved mobility and quality of life. Etodolac works by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), which are responsible for producing prostaglandins, the chemical mediators of inflammation and pain in the body. This mechanism reduces the severity of symptoms like swelling, redness, and tenderness in affected areas. Beyond arthritis, Edofoam 600 Tablet is also beneficial in controlling acute musculoskeletal pain and reducing post-surgical discomfort. Its long-lasting effect ensures sustained relief, making it a reliable option for chronic and acute conditions. While providing symptomatic relief, it does not cure the underlying condition, so it is typically used as part of a comprehensive treatment plan.

Read More

About the Product

Edofoam 600 Tablet contains Etodolac (600mg), a potent non-steroidal anti-inflammatory drug (NSAID) designed to alleviate pain and inflammation associated with various conditions. It is particularly effective in managing arthritis-related discomforts, including stiffness, swelling, and joint pain, offering patients improved mobility and quality of life. Etodolac works by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), which are responsible for producing prostaglandins, the chemical mediators of inflammation and pain in the body. This mechanism reduces the severity of symptoms like swelling, redness, and tenderness in affected areas. Beyond arthritis, Edofoam 600 Tablet is also beneficial in controlling acute musculoskeletal pain and reducing post-surgical discomfort. Its long-lasting effect ensures sustained relief, making it a reliable option for chronic and acute conditions. While providing symptomatic relief, it does not cure the underlying condition, so it is typically used as part of a comprehensive treatment plan.

Common side effects may include gastrointestinal disturbances, such as nausea, heartburn, or indigestion. Long-term use may increase the risk of gastrointestinal ulcers, kidney damage, or cardiovascular events. Allergic reactions such as rash or swelling may also occur in some individuals

Edofoam 600 Tablet is indicated for the relief of symptoms associated with osteoarthritis, rheumatoid arthritis, and acute musculoskeletal pain. It is also effective in treating pain after surgery and reducing inflammation caused by injury.

Always take this medication as prescribed. Do not exceed the recommended dose to avoid potential side effects, particularly on the stomach and kidneys.

Store in a cool, dry place away from direct sunlight. Keep the medication out of reach of children and in its original packaging to protect from moisture.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation